Back to Search
Start Over
Developing a low-cost and accessible COVID-19 vaccine for global health.
- Source :
-
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Jul 29; Vol. 14 (7), pp. e0008548. Date of Electronic Publication: 2020 Jul 29 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: The authors have developed subunit vaccines against SARS and MERS coronavirus infections. They are involved in the process of developing a vaccine against SARS-CoV-2.
- Subjects :
- Animals
Antibodies, Neutralizing immunology
Antibodies, Viral immunology
COVID-19
COVID-19 Vaccines
Coronavirus Infections economics
Coronavirus Infections immunology
Cross Protection
Developing Countries
Humans
Neutralization Tests
Protein Interaction Domains and Motifs
Severe acute respiratory syndrome-related coronavirus immunology
SARS-CoV-2
Severe Acute Respiratory Syndrome prevention & control
Spike Glycoprotein, Coronavirus chemistry
Spike Glycoprotein, Coronavirus immunology
Technology Transfer
Vaccines, Subunit adverse effects
Vaccines, Subunit economics
Vaccines, Subunit immunology
Vaccines, Subunit supply & distribution
Vaccines, Synthetic adverse effects
Vaccines, Synthetic economics
Vaccines, Synthetic immunology
Betacoronavirus immunology
Coronavirus Infections prevention & control
Global Health
Pandemics prevention & control
Pneumonia, Viral prevention & control
Viral Vaccines adverse effects
Viral Vaccines economics
Viral Vaccines immunology
Viral Vaccines supply & distribution
Subjects
Details
- Language :
- English
- ISSN :
- 1935-2735
- Volume :
- 14
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- PLoS neglected tropical diseases
- Publication Type :
- Academic Journal
- Accession number :
- 32726304
- Full Text :
- https://doi.org/10.1371/journal.pntd.0008548